More than 80% of patients with Parkinson's disease (PD) develop dysphagia during the
course of their disease. Swallowing impairment reduces quality of life, complicates …

Objective To summarize the 2010 EFNS/MDS‐ES evidence‐based treatment
recommendations for the management of P arkinson's disease (PD). This summary includes …

Only a few years after the introduction of levodopa, the first descriptions of motor fluctuations
and dyskinesia related to dopaminergic therapy appeared. In PD, attention turned to their …

As with other neurodegenerative diseases, neurologic and nutritional elements may interact
affecting each other in Parkinson's disease (PD). However, the long‐term effects of such …

Various methods of rehabilitation for dysphagia have been suggested through the
experience of treating stroke patients. Although most of these patients recover their …

A diagnosis of Parkinson's disease is classically established after the manifestation of motor
symptoms such as rigidity, bradykinesia, and tremor. However, a growing body of evidence …

Parkinson's Disease (PD) is currently considered a systemic neurodegenerative disease
manifested with not only motor but also non-motor symptoms. In particular, weight loss and …

Background Dysphagia is common in Parkinson's disease (PD). The effects of
antiparkinsonian drugs on dysphagia are controversial. Several treatments for dysphagia …

Speech and swallowing disorders in Parkinson disease : Current Opinion in Otolaryngology &
Head and Neck Surgery Speech and swallowing disorders in Parkinson disease : Current …

When formulating a DBS treatment plan for a patient with Parkinson's disease (PD), two
critical questions should be addressed:(1) Which brain target should be chosen to optimize …